CVAC Systems, Inc. and Athercare Fitness & Rehabilitation announce their agreement to study the value of the CVAC process in fitness and athletic performance enhancement, and to explore this use in a commercial environment.
Cambridge Devices, a medical device company that develops real-time pathology solutions, has completed a $2.5M round of seed funding from Kodiak Venture Partners, and welcomes MIT Professor Dr. Anthony Sinskey to its board of directors.
There are many pharmaceutical options to treat hypertension, but traditionally, treatment options have been limited for those patients who do not respond to drug therapies.
On-going CAS data from several trials, such as the Stenting Angioplasty Protection Patients High Risk Endarterectomy (SAPPHIRE) and capture trials were debated in New York today at the 33rd annual VEITHsymposium™.
Israeli author Kfir Luzzatto's new book, "The Odyssey Gene," addresses genetic discrimination, which could be a very real concern in the near future. Scientists say that by 2010 we will be able to purchase genetic testing kits for the mere price of $100. "The Odyssey Gene" shares the tale of one man's plight to overcome the discrimination he faces after such a test discloses he is different from other people.